FitLife Brands, Inc. — Form 10-Q Summary
Business Context and Reporting Period
FitLife Brands, Inc. develops, manufactures and distributes nutritional supplements under the NDS, PMD, SirenLabs, CoreActive and Metis brands, primarily through franchised GNC locations in the United States and internationally. This unaudited Form 10-Q covers the quarter and six months ended June 30, 2015, filed August 13, 2015. The company is classified as a small reporting company and trades on the OTCBB under FTLF.
Financial Results and Position
| Metric | Three Months Ended June 30, 2015 | Three Months Ended June 30, 2014 | Six Months Ended June 30, 2015 | Six Months Ended June 30, 2014 |
|---|---|---|---|---|
| Revenue | $5.03 million | $5.99 million | $8.87 million | $12.32 million |
| Gross profit | $1.94 million | $2.25 million | $3.51 million | $4.61 million |
| Gross margin | 38.5% | 37.6% | 39.6% | 37.4% |
| Operating income | $287,175 | $816,591 | $271,561 | $1.74 million |
| Net income | $243,537 | $725,215 | $201,274 | $1.62 million |
| Basic diluted EPS | $0.03 / $0.03 | $0.09 / $0.08 | $0.02 / $0.02 | $0.20 / $0.19 |
Second-quarter operating margin declined to approximately 5.7% from 13.6%; six-month operating margin declined to approximately 3.1% from 14.2%. Second-quarter net margin was approximately 4.8% versus 12.1% in the prior-year period; six-month net margin was approximately 2.3% versus 13.1%.
- Cash was $4.34 million at June 30, 2015, compared with $4.35 million at December 31, 2014.
- Net cash provided by operating activities was $560,156 for the six months, down from $811,692.
- Investing cash flow was negative $326,902, principally due to $324,688 of share repurchases.
- Financing cash flow was negative $251,312, reflecting term-loan principal repayments.
- Total debt was $2.13 million, consisting of a $437,089 revolving line of credit and a $1.70 million term loan. The current portion of debt was $953,316 and long-term debt was $1.18 million.
- Total assets were $10.95 million and stockholders’ equity was $6.93 million at June 30, 2015.
- Accounts receivable increased to $2.97 million from $1.69 million at year-end 2014, principally due to the transition to GNC’s centralized distribution platform. Inventory declined to $1.84 million from $2.28 million.
Material Changes Versus the Prior Comparable Period
- Revenue declined 16% in the second quarter and 28% for the six months. Management attributed the decline to approximately $3.0 million of non-recurring prior-year inventory build-out revenue, a $1.2 million order backlog caused by manufacturer supply disruptions, and pricing discounts associated with the GNC distribution transition.
- Gross profit declined in absolute dollars, but gross margin improved modestly due partly to lower direct costs under the GNC platform.
- Operating income and net income fell substantially because of lower sales, higher selling and marketing costs, and approximately $223,000 of iSatori acquisition-related general and administrative expenses during the quarter.
- Selling and marketing expense increased to $910,953 in the quarter and $1.51 million year to date, driven by product rebates, the Metis launch and participation in the GNC franchise convention.
- The company repurchased 39,446 shares during the quarter for approximately $68,707 and had repurchased 159,800 shares at an average price of $2.03 per share as of August 13, 2015.
Guidance, Outlook, Risks and Unusual Items
- Management expected the supply backlog and related disruptions to be largely resolved during the third quarter of 2015. It also expected the impact of GNC pricing changes to lessen in future comparisons.
- The company introduced 20 products at the June-July 2015 GNC franchise convention and expected new products, Metis expansion, additional GNC locations and international growth to support future revenue, although no assurance was provided.
- Management stated that cash on hand and anticipated operating cash flow should provide liquidity for the next 12 months.
- On May 18, 2015, FitLife entered into a proposed merger agreement to acquire iSatori. The transaction was subject to shareholder approval and other conditions and was expected to issue approximately 4.0 million FitLife shares, subject to adjustment. The agreement included potential $200,000 termination fees and arrangements concerning repurchase and first-refusal rights over certain shares.
- Pending legal matters included a California Proposition 65 notice concerning product labeling and a stayed putative class action involving Testofen-related claims. The company could not reasonably estimate potential exposure from the Proposition 65 matter.
- The company reported no defaults on senior securities, no new risk factors beyond those in its 2014 Form 10-K, and no impairment events for long-lived assets. Management concluded that disclosure controls and internal control over financial reporting were effective.
- The company had approximately $19.1 million of federal net operating loss carryforwards, but maintained a substantial valuation allowance. Future use may be limited by Section 382 and other tax rules.
Investor Verification Items
- Verify whether the expected third-quarter resolution of supply disruptions occurred and whether the $1.2 million backlog converted into revenue.
- Assess the sustainability of revenue and margins after the GNC centralized-distribution transition, including the effect of pricing discounts and rebates.
- Review the status, final consideration, share issuance and integration consequences of the proposed iSatori merger.
- Monitor cash conversion, particularly the elevated accounts receivable balance and operating cash flow relative to reported net income.
- Confirm debt maturities, borrowing-base availability and interest-rate exposure under the revolving line of credit.
- Review developments and possible financial exposure related to the Proposition 65 matter and the Testofen litigation.
- Reconcile the filing’s differing common-share figures, including 8,043,525 shares shown on the balance sheet, 8,082,971 shares stated in the equity note, and 8,049,339 shares reported outstanding as of August 12, 2015.